{"database": "lobbying", "table": "lobbying_activities", "rows": [[1416612, "84943093-4f61-46b4-b7de-1729a95b1fd7", "2T", "RASKY PARTNERS, INC.", 297410, "ELI LILLY AND CO", 2013, "second_quarter", "PHA", "Monitor biologics related issues, Medicare Part D", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 1, "2013-07-19T11:19:05.893000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1416612"], "units": {}, "query_ms": 3.1309430487453938, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}